Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide
Iris Maria Forte(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Antonio Giordano(University of Siena)
Cited by 42
Related Papers
Curcumin and Cancer
|Nutrients|2019|977
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
|Breast Cancer Research|2011|224
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205